ClinicalTrials.gg

Program

donidalorsen

Its studies are mostly in Angioedemas, Hereditary, led by Ionis Pharmaceuticals.

Furthest: phase 3, since Nov 18, 20216 company-led studies, 2 open or runningNext primary completion: Dec 2026 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Ionis Pharmaceuticals62 open or runningphase 3since Nov 18, 2021Aug 17, 2017Dec 2026phase 3 · NCT05392114

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Aug 17, 2017First study: phase 1 study in Healthy VolunteersFirst studyNCT03263507 · 32 enrolled · Canada
  2. Jul 22, 2019Phase 2 study in Angioedemas, HereditaryNCT04030598 · 23 enrolled · United States, Netherlands
  3. Mar 11, 2020Phase 2 study in Angioedemas, HereditaryNCT04307381 · 20 enrolled · United States, Netherlands
  4. Nov 18, 2021Phase 3 study in Angioedemas, HereditaryNCT05139810 · 91 enrolled · United States, Belgium, Bulgaria and more
  5. May 23, 2022Phase 3 study in Angioedemas, HereditaryNCT05392114 · 154 enrolled · United States, Belgium, Bulgaria and more
  6. Dec 19, 2025Phase 3 study in Angioedemas, HereditaryNCT07298447 · 20 planned · United States, Australia, Italy and more

Ahead

  1. Dec 2026Primary completion: phase 3 study in Angioedemas, HereditaryNCT05392114
  2. Jun 2029Primary completion: phase 3 study in Angioedemas, HereditaryNCT07298447

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 6 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07298447Angioedemas, Hereditary · United States, Australia, Italy and more3RecruitingJun 202920
NCT05392114Angioedemas, Hereditary · United States, Belgium, Bulgaria and more3Active, not recruitingDec 2026154
NCT05139810Angioedemas, Hereditary · United States, Belgium, Bulgaria and more3CompletedNov 9, 202391
NCT04307381Angioedemas, Hereditary · United States, Netherlands2CompletedJan 24, 202520
NCT04030598Angioedemas, Hereditary · United States, Netherlands2CompletedJan 4, 202123
NCT03263507Healthy Volunteers · Canada1CompletedOct 9, 201832

How it is read

Names in the registry

  • “Donidalorsen”, 6 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.